LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,093
تعداد مقالات10,025
تعداد مشاهده مقاله27,288,200
تعداد دریافت فایل اصل مقاله7,503,738
Noori, Shokoofe, Mohammad Hassan, Zuhair, Salehian, Omid. (1391). Sclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo. سامانه مدیریت نشریات علمی, 10(1), 10-21.
Shokoofe Noori; Zuhair Mohammad Hassan; Omid Salehian. "Sclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo". سامانه مدیریت نشریات علمی, 10, 1, 1391, 10-21.
Noori, Shokoofe, Mohammad Hassan, Zuhair, Salehian, Omid. (1391). 'Sclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo', سامانه مدیریت نشریات علمی, 10(1), pp. 10-21.
Noori, Shokoofe, Mohammad Hassan, Zuhair, Salehian, Omid. Sclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo. سامانه مدیریت نشریات علمی, 1391; 10(1): 10-21.

Sclareol Reduces CD4+ CD25+ FoxP3+ T-reg Cells in a Breast Cancer Model in Vivo

Iranian Journal of Immunology
مقاله 2، دوره 10، شماره 1، خرداد 2013، صفحه 10-21    اصل مقاله (745.83 K)
نوع مقاله: Original Article
نویسندگان
Shokoofe Noori* 1؛ Zuhair Mohammad Hassan2؛ Omid Salehian3
1Department of Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences
2Department of Immunology, School of Medical Sciences, Tarbiat Modares University
3Department of Exercise Physiology, Tehran University, Tehran, Iran
چکیده
Background: Sclareol is a phytochemical used in people's diet in Southeast Asia.
Objective: To investigate the immunotherapeutic effectiveness of Sclareol against breast cancer by direct intraperitoneal injection.
Methods: Sclareol was isolated and purified from Salvia sclarea. Effect of Sclareol on cell growth inhibition was evaluated by MTT assay. Intraperitoneally injected Sclareol effects on reducing the tumor volume and shifting the cytokine profile were investigated. We also assessed if intraperitoneally injected Sclareol could improve the outcome of cancer therapy through suppressing the regulatory T cells.
Results: The results confirmed a significant decrease in the tumor size. Furthermore, a significant decrease in the level of IL-4 and an increase in the level of IFN-γ were noticed in the intraperitoneally injected Sclareol group (p<0.05). It was also observed that the splenocytes of treated animals significantly increase in cell proliferation assay. Moreover, measurements of splenic T regulatory cell indicated that intraperitoneally injected Sclareol significantly decreased the number of splenic T regulatory cell.
Conclusion: Our results suggest that Sclareol, by reducing T-reg cells frequency and also tumor size can enhance the effect of cancer therapy as an immunostimulant.
کلیدواژه‌ها
IFN-γ؛ IL-4؛ Immunomodulator؛ Sclareol؛ T Regulatory Cell
آمار
تعداد مشاهده مقاله: 1,603
تعداد دریافت فایل اصل مقاله: 1,155


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب